Clinical trial
Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes…
NCT00391209 · Eli Lilly and Company, Industry · Completed
Key facts
| NCT number | NCT00391209 |
|---|---|
| Title | Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus |
| Official title | A Phase 3, Open-Label, Parallel-Group Study to Compare Two Dosing Algorithms for Preprandial Human Insulin Inhalation Powder (HIIP) in Insulin-Naive Patients With Type 2 Diabetes Mellitus |
| Lead sponsor | Eli Lilly and Company, Industry |
| Collaborators | Alkermes, Inc. Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | simplified diabetes regimen starting with a fixed dose of Human Insulin Inhalation Powder, intensive diabetes management starting with an adjusted dose of Human Insulin Inhalation Powder |
| Enrollment | 379 |
| Start date | Oct 1, 2006 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Oct 23, 2006 |
| Last update posted | Mar 9, 2018 |
| Countries | Argentina, Austria, Belgium, France, India, Mexico, Puerto Rico, Spain, United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: